Coreline Soft Co., Ltd
Founded in 2012, Coreline Soft provides the AI-based chest CT diagnostic aid suite AVIEW for lung nodules, COPD, and coronary calcification.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2012 and listed on KOSDAQ in 2023, Coreline Soft is an AI-based medical imaging software company. Its flagship chest CT analysis products are AVIEW LCS (lung nodule diagnosis aid, launched 2016), AVIEW COPD (chronic obstructive pulmonary disease diagnosis aid, 2016), and AVIEW CAC (coronary artery calcification diagnosis aid, 2020), with the product line expanded to include diagnostic aids for cerebral hemorrhage, aortic dissection, and pulmonary embolism. AVIEW LCS began hospital services through Korea's National Cancer Center, and after establishing a European subsidiary in 2020 and a US subsidiary in 2021, the company secured Germany's HANSE lung cancer screening program, Italy's ILSP lung cancer screening project, and the six-country European 4-ITLR multinational lung cancer screening project.
Products & technology
- AVIEW LCSAI-based automatic lung nodule analysis (launched 2016)
- AVIEW LCS PLUSAI-based automatic analysis of Big 3 Disease: lung nodule, emphysema, coronary calcification (launched 2020)
- AVIEW COPDAI-based automatic COPD analysis (launched 2016)
- AVIEW CACAI-based automatic coronary artery calcification analysis (launched 2020)
- AVIEW Lung TextureAI-based automatic interstitial lung disease pattern analysis (launched 2021)
- AVIEW BASAI-based cerebral vascular structure visualization (launched 2021)
- AVIEW NeuroCADAI-based cerebral hemorrhage analysis and diagnosis aid (launched 2021)
- AVIEW RT ACSAI-based automatic organ segmentation for radiotherapy (launched 2020)
- AVIEW ModelerAutomatic/semi-automatic medical image segmentation for 3D modeling and printing (launched 2017)
- AVIEW ResearchResearch medical imaging data management and integrated research platform (launched 2018)
- AVIEW AortaAI-based aortic dissection diagnosis aid (launched 2024)
- AVIEW PEAI-based pulmonary embolism diagnosis aid (launched 2024)
Regulatory approvals
data.go.kr · openFDA3 Innovative Medical Device designations · 2020–2024 / 28 Korean MFDS device approvals · 2016–2026 / 12 US FDA 510(k) · 2018–2025
- InnovativeAVIEW PE2024-06-26Innovative Medical Device designation
- InnovativeAVIEW Aorta2024-02-21Innovative Medical Device designation
- InnovativeAVIEW NeuroCAD2020-11-17Innovative Medical Device designation
- MFDSProduct name not recorded2026-07-10Product approval · Class 2인 26-4028 호
- MFDSProduct name not recorded2026-06-01Product approval · Class 1신 26-61 호
- MFDSProduct name not recorded2026-04-24Product approval · Class 1신 26-49 호
- MFDSProduct name not recorded2026-03-19Product approval · Class 1신 26-32 호
- FDAAVIEW Lung Nodule CAD2025-12-03
- MFDSProduct name not recorded2025-05-02Product approval · Class 1신 25-6 호
- MFDSMedical image, computer aided detection/ diagnosis software, class 32025-03-25Product approval · Class 3제허 25-184 호
- FDAAVIEW2025-03-19
- FDAAVIEW CAC2025-02-14
Show 31 more
- MFDSMedical image, picture archiving and communication system, software, class 12024-12-02Product approval · Class 1제신 24-1499 호
- MFDSProduct name not recorded2024-12-02Product approval · Class 1신 24-1499 호
- MFDSMedical image, analysis software2024-08-08Product approval · Class 2제인 24-767 호
- MFDSMedical image, computer aided detection/ diagnosis software, class 22024-07-26Product approval · Class 2제허 24-504 호
- MFDSCardiovascular image, computer aided detection/ diagnosis software2024-04-30Product approval · Class 3제허 24-301 호
- MFDSMedical image, computer aided detection/ diagnosis software, class 22024-04-29Product approval · Class 2제인 24-446 호
- FDAAVIEW CAC2024-03-29
- MFDSMedical image, analysis software2024-01-16Product approval · Class 2제인 24-55 호
- MFDSMedical image, analysis software2023-09-01Product approval · Class 2제인 23-5060 호
- MFDSProduct name not recorded2023-09-01Product approval · Class 2인 23-5060 호
- FDAAVIEW Lung Nodule CAD2023-02-24
- MFDSCardiovascular image, analysis software2023-02-01Product approval · Class 2제인 23-4121 호
- MFDSProduct name not recorded2023-02-01Product approval · Class 2인 23-4121 호
- FDAAVIEW2022-12-23
- FDAAVIEW RT ACS2022-11-10
- MFDSNeural image, computer aided detection/diagnosis software2021-12-15Product approval · Class 3제허 21-1013 호
- MFDSCardiovascular image, computer aided detection/ diagnosis software2021-07-02Product approval · Class 3제허 21-554 호
- MFDSNeural image, analysis software2021-04-19Product approval · Class 2제인 21-4318 호
- MFDSProduct name not recorded2021-04-19Product approval · Class 2인 21-4318 호
- FDAA View LCS2020-10-16
- FDAAVIEW2020-08-26
- MFDSMedical image, analysis software2020-07-16Product approval · Class 2제인 20-4631 호
- MFDSProduct name not recorded2020-07-16Product approval · Class 2인 20-4631 호
- MFDSMedical image, computer aided detection/ diagnosis software, class 22020-06-16Product approval · Class 2제허 20-484 호
- FDAAVIEW LCS2020-05-05
- MFDSMedical image, computer aided detection/ diagnosis software, class 22020-04-21Product approval · Class 2제허 20-298 호
- FDAAVIEW Modeler2019-12-20
- FDAAVIEW2018-10-31
- MFDSGuide for medical useRevoked2016-12-12Product approval · Class 1제신 16-1472 호
- MFDSMedical image, analysis software2016-07-21Product approval · Class 2제인 16-4603 호
- MFDSProduct name not recorded2016-07-21Product approval · Class 2인 16-4603 호
AI reads
MAA server logs · IP-verifiedSomeone asked an AI a question, and it fetched this page live to answer.
Collected for later use. Not a signal of interest.
- OpenAIChatGPT-Useranswer1
Measured since Aug 25, 2026 · 1 AI engines · last read Aug 25, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS.
Companies approved for the same productsMedical AI
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded in 2008 and listed on KOSDAQ in 2021, DEEPNOID develops medical and industrial AI imaging solutions like DEEP:NEURO.
JLK offers the stroke AI solution MEDIHUB STROKE and holds 78 global regulatory approvals, including US FDA and Japan PMDA clearances.
Founded in 2014, VUNO provides AI-based vital-sign and medical imaging diagnostic solutions, including VUNO Med-DeepCARS and VUNO Med-Fundus AI.
Founded in 2016 and listed on KOSDAQ in 2025, Neurophet develops AI brain-imaging solutions AQUA, SCALE PET, and AQUA AD.
Uses AI analysis of medical imaging to 3D-print patient-specific surgical guides, implants, and simulators.
Founded in 1997 and KOSDAQ-listed in 2015, CG MedTech makes orthopedic medical devices and also operates an electric energy business.
Founded in 2000 and KOSDAQ-listed in 2013, Corentec makes artificial joints; hip and knee implants exceed 85% of revenue.
Founded in 2016 and listed on KOSDAQ in 2017, DENTIS manufactures dental implants, medical LED lighting, and dental 3D printers.
Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.
Provides EMS and SMT manufacturing services for TFT-LCD and OLED panel driver PBAs.
KOSDAQ-listed X-ray imaging solution company with a full lineup of medical, dental, veterinary, and industrial X-ray detectors.
Founded in 1982 and KOSDAQ-listed in 2008, Sewoon Medical manufactures medical aspirators and catheters/tubes.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition